1. Home
  2. CGTX vs ASRV Comparison

CGTX vs ASRV Comparison

Compare CGTX & ASRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • ASRV
  • Stock Information
  • Founded
  • CGTX 2007
  • ASRV 1983
  • Country
  • CGTX United States
  • ASRV United States
  • Employees
  • CGTX N/A
  • ASRV N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • ASRV Major Banks
  • Sector
  • CGTX Health Care
  • ASRV Finance
  • Exchange
  • CGTX Nasdaq
  • ASRV Nasdaq
  • Market Cap
  • CGTX 53.4M
  • ASRV 51.0M
  • IPO Year
  • CGTX 2021
  • ASRV N/A
  • Fundamental
  • Price
  • CGTX $1.54
  • ASRV $2.97
  • Analyst Decision
  • CGTX Strong Buy
  • ASRV
  • Analyst Count
  • CGTX 3
  • ASRV 0
  • Target Price
  • CGTX $2.83
  • ASRV N/A
  • AVG Volume (30 Days)
  • CGTX 8.5M
  • ASRV 17.7K
  • Earning Date
  • CGTX 08-07-2025
  • ASRV 07-22-2025
  • Dividend Yield
  • CGTX N/A
  • ASRV 4.04%
  • EPS Growth
  • CGTX N/A
  • ASRV N/A
  • EPS
  • CGTX N/A
  • ASRV 0.22
  • Revenue
  • CGTX N/A
  • ASRV $51,581,000.00
  • Revenue This Year
  • CGTX N/A
  • ASRV N/A
  • Revenue Next Year
  • CGTX N/A
  • ASRV N/A
  • P/E Ratio
  • CGTX N/A
  • ASRV $13.47
  • Revenue Growth
  • CGTX N/A
  • ASRV 13.95
  • 52 Week Low
  • CGTX $0.22
  • ASRV $2.03
  • 52 Week High
  • CGTX $1.97
  • ASRV $3.42
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 77.80
  • ASRV 52.47
  • Support Level
  • CGTX $1.15
  • ASRV $2.90
  • Resistance Level
  • CGTX $0.74
  • ASRV $3.15
  • Average True Range (ATR)
  • CGTX 0.19
  • ASRV 0.10
  • MACD
  • CGTX 0.09
  • ASRV 0.01
  • Stochastic Oscillator
  • CGTX 69.59
  • ASRV 64.71

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About ASRV AmeriServ Financial Inc.

AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.

Share on Social Networks: